May 5, 2019

Avanti Biosciences is awarded the second phase of the fast track SBIR grants from the NIA for work on Alzheimer's Disease.

​

July 30, 2018

Avanti Biosciences receives $300,000 SBIR Phase 1 grant from the NIDDK for the development of new therapies for the treatment of Hyperinsulinemia Hyperammonemia Syndrome in collaboration with the Children Hospital of Philadelphia (CHOP)

​

May 1, 2018

Avanti Biosciences open new operations in the JLAB San Diego.

​

August 15, 2017

Avanti Biosciences Receives $1.9M SBIR Fast-Track Award to Further Treatment for Alzheimer’s Disease

​

October 8, 2015

Avanti Biosciences approved by the Long Island High Technology Incubator (LIHTI) as part of the Incubator Without Walls Program initiative.